Multi-measurement method comparison of three commercial hepatitis B virus DNA quantification assays

Journal of Viral Hepatitis

Volumn 5, Issue 6, 1998, Pages 415-422

  Krajden, M ^a,b,d   Minor, J ^c   Cork, L ^b   Comanor, L ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Toronto Medical Laboratories   (Canada)

^c NOVARTIS PHARMA AG   (Switzerland)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Chronic hepatitis B; HBV DNA; Interferon; Multi measurement method (MMM); Spontaneous seroconversion; Statistical models

Indexed keywords

INTERFERON; VIRUS DNA;

ARTICLE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MEASUREMENT; PRIORITY JOURNAL; STATISTICAL MODEL; TECHNIQUE;

DNA, VIRAL; EVALUATION STUDIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MODELS, STATISTICAL; NUCLEIC ACID HYBRIDIZATION; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 0031768376     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1998.00129.x     Document Type: Article

References (24)

1. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M. Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657-1661.
2. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347-356.
3. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996; 93: 4398-4402.
4. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1746.
5. Butterworth IM, Prior SL, Buda PJ, Faoagalo JL, Cooksley WGE. Comparison of four methods for quantitative measurement of hepatitis B viral DNA. J Hepatol 1996; 24: 686-691.
6. Hendricks DA, Stowe BJ, Hoo BS et al. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 1995; 104: 537-546.
7. Kapke GF, Watson G, Sheffler S, Hunt D, Frederick C. Comparison of the Chiron Quantiplex branched DNA (bDNA) assay and the Abbott Genostics solution hybridization assay for quantification of hepatitis B viral DNA. J Viral Hep 1997; 4: 67-75.
8. Pawlotsky J-M, Bastie A, Lonjon I et al. What technique should be used for routine detection and quantification of HBV DNA in clinical samples? J Virol Methods 1997; 65: 245-253.
9. Zaaijer HL, ter Borg F, Cuypers HTM, Hermus MCAH, Lelie PN. Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol 1994; 32: 2088-2091.
10. Hollis S. Analysis of method comparison studies. Ann Clin Biochem 1996; 33: 1-4.
11. Kuhns MC, McNamara AL, Cabal CM et al. A new assay for the quantitative detection of hepatitis B viral DNA in human serum. In: Zuckerman AJ, ed. Viral Hepatitis and Liver Disease. New York: Alan R. Liss, Inc., 1988: 258-262.
12. Bard Y. Nonlinear Parameter Estimation. New York: Academic Press, 1974.
13. Martens H, Naes T. Multivariate Calibration. New York: Wiley, 1989.
14. Ritter J, Girault V, Chevallier P, Guichard E, Parvaz P. Sepetjan M. HBV DNA assay by hybridization in solution. Value of low levels measured with the Abbott-Genostics device. Pathol Biol (Paris) 1994; 42: 884-887.
15. Lau DT-Y, Comanor L, Minor JM, Everhart JE, Wuestehube LJ, Hoofnagle JH. Statistical models for predicting a beneficial response to interferon-alpha in patients with chronic hepatitis B. J Viral Hep 1998; 5: 105-114.
16. Sato S, Suzuki K, Akahane Y et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995; 122: 241-248.
17. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1699-1704.
18. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991; 324: 1705-1709.
19. Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995; 332: 1065-1069.
20. Thomas HC, Foster GR, Sumiya M et al. Mutation of gene for mannose-binding protein associated with chronic hepatitis B viral infection. Lancet 1996; 348: 1417-1419.
21. Lindh M, Horal P, Dhillon AP, Furuta Y, Norkans G. Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage. Hepatology 1996; 24: 494-501.
22. Sitterlin D, Lee T-H, Prigent S, Tiollais P, Butel JS, Transy C. Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants. J Virol 1997; 71: 6194-6199.
23. Yamada T, De Souza AT, Finkelstein S, Jirtles RL. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci USA 1997; 94: 10351-10355.
24. National Committee for Clinical Laboratory Standards. NCCLS Evaluation Protocols, Order Code SCI-L. Wayne, PA: NCCLS, 1996.